Cellebrite DI (CLBT) Stock Price Target 2026

The average analyst price target for Cellebrite DI is $18.65, 46.0% above the current price. Of 9 analysts, 9 rate it Buy. Targets range from $12 to $26. The latest change came on Aug 14, 2026, when Lake Street lowered its price target on Cellebrite DI from $21 to $15 and kept a Buy rating.

The Average Analyst Price Target for Cellebrite DI is $18.65.

Price Target Range — 11 Quarters

Analyst Consensus — 9 Analysts

9Buy

Consensus RatingBuy# Analysts9Avg. Consensus PT$18.65Upside to Avg. PT+46.0%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Cellebrite DI Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 15, 2026	DA Davidson	Rudy Kessinger	Maintained	Buy	$15
Aug 14, 2026	Lake Street	Eric Martinuzzi	PT Cut	Buy	$21→$15
Aug 14, 2026	JP Morgan	Brian Essex	PT Cut	Overweight	$20→$16
Aug 14, 2026	DA Davidson	Rudy Kessinger	PT Cut	Buy	$22→$15
Aug 14, 2026	Needham	Mike Cikos	PT Cut	Buy	$15→$13
Aug 6, 2026	DA Davidson	Rudy Kessinger	PT Raise	Buy	$20→$22
May 27, 2026	DA Davidson	Rudy Kessinger	Initiate	Buy	$20
May 15, 2026	Needham	Mike Cikos	PT Cut	Buy	$18→$15
Feb 12, 2026	Needham	Mike Cikos	PT Cut	Buy	$24→$18
Nov 13, 2025	JP Morgan	Brian Essex	PT Raise	Overweight	$23→$24
Nov 13, 2025	Lake Street	Eric Martinuzzi	PT Raise	Buy	$22→$23
Nov 13, 2025	B of A Securities	Tal Liani	PT Raise	Buy	$24→$25
Nov 13, 2025	Needham	Mike Cikos	PT Raise	Buy	$22→$24
Sep 24, 2025	JP Morgan	Brian Essex	PT Raise	Overweight	$20→$23
Aug 15, 2025	Lake Street	Eric Martinuzzi	PT Cut	Buy	$24→$22
Aug 14, 2025	Needham	Mike Cikos	PT Cut	Buy	$24→$18
Jun 23, 2025	JP Morgan	Brian Essex	PT Cut	Overweight	$22→$20
Jun 6, 2025	Needham	Mike Cikos	Maintained	Buy	$24
May 15, 2025	JP Morgan	Brian Essex	PT Cut	Overweight	$25→$22
May 14, 2025	Needham	Mike Cikos	PT Cut	Buy	$28→$24